Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT00796120
Status:
COMPLETED
Last Update Posted:
2015-12-10
First Post:
2008-11-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-20
First Submit QC Date:
None
Study First Post Date:
2008-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-25
Results First Submit QC Date:
None
Results First Post Date:
2014-09-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-04-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-12-09
Last Update Post Date:
2015-12-10
Last Update Post Date Type:
ESTIMATED